‘Nightmare bacteria’ are rapidly spreading
The infections are largely resistant to antibiotics


Nightmare bacteria are very much the stuff of waking life. These microbes pose a “triple threat” to humanity because they are “resistant to all or nearly all antibiotics,” they have “high mortality rates” and they can “spread their resistance to other bacteria,” said the former Centers for Disease Control and Prevention (CDC) director Tom Frieden in 2013. Nightmare bacteria infections have increased significantly since then and are likely to cause more deaths over time.
Drugged and dangerous
Infections from nightmare bacteria rose by almost 70% between 2019 and 2023 in the U.S., according to a report published in the journal Annals of Internal Medicine by CDC scientists. The report specifically refers to the rise of infections from a certain group of bacteria called Enterobacterales. These bacteria are resistant to a wide range of antibiotics, including carbapenems, which are used to treat “severe multidrug-resistant bacterial infections,” said Scientific American.
Many of these bacteria are hard to treat because of what is called the “NDM” gene, which “creates an enzyme that destroys antibiotics,” said Axios. Bacteria with the gene can only be treated with two antibiotics, both of which are expensive and have to be administered through an IV. “The rise of NDMs in the U.S. is a grave danger and very worrisome,” David Weiss, an infectious disease researcher at Emory University, said to The Associated Press. While the rate of carbapenem-resistant Enterobacterales (CRE) infections increased by approximately 69% between 2019 and 2023, the rate of CRE infections with the NDM gene jumped by a staggering 461%.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It is also likely that “many people are unrecognized carriers of the drug-resistant bacteria, which could lead to community spread,” said the AP. “That may play out in doctors’ offices across the country, as infections long considered routine” become more difficult to treat. CRE infections can include “pneumonia, bloodstream infections, UTIs, wound infections and meningitis,” said the CDC.
Growing resistance
Antibiotic resistance is a growing problem worldwide. “Bacteria with the gene were once considered exotic, linked to a small number of patients who received medical care overseas,” said the AP. There could be a few reasons for why this has since shifted. NDM-CRE can “spread from improper hand hygiene among health care providers or inadequate cleaning and disinfection of equipment,” said Scientific American. “Insufficient testing and limited access to detection tools” could also play a role. “When NDM-CRE infections are not identified quickly, earlier treatment with effective antibiotics and infection control interventions may be delayed, which can then create more opportunities for transmission from patient to patient,” Danielle Rankin, a co-author of the study and an epidemiologist at the CDC’s Division of Healthcare Quality Promotion, said to Scientific American.
Covid-19 may have also contributed to the rise of antibiotic resistance. “We know that there was a huge surge in antibiotic use during the pandemic, so this likely is reflected in increasing drug resistance,” Jason Burnham, a researcher at Washington University, said to the AP. It is important to take antibiotics exactly as prescribed to avoid promoting resistance.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
October 19 editorial cartoons
Cartoons Sunday's editorial cartoons include Pete Hegseth and the press, an absence of government, and George Washington crossing the Delaware
-
A little-visited Indian Ocean archipelago
The Week Recommends The paradise of the Union of the Comoros features beautiful beaches, colourful coral reefs and lush forests
-
AI: is the bubble about to burst?
In the Spotlight Stock market ever-more reliant on tech stocks whose value relies on assumptions of continued growth and easy financing
-
Doctors sound the alarm about insurance company ‘downcoding’
The Explainer ‘It’s blatantly disrespectful,’ one doctor said
-
Climate change is getting under our skin
Under the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?
Today's Big Question California law and the MAHA movement are on the same track
-
Bluetoothing: the phenomenon driving HIV spike in Fiji
Under the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Can TrumpRx really lower drug prices?
Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Kissing bug disease has a growing presence in the US
The explainer The disease has yielded a steady stream of cases in the last 10 years